19/12/2014 06:44:52 Free Membership Login

   

Affymax, Inc.

Visual Financials
Company Name: Affymax, Inc.
Ticker Symbol: AFFY
WWW Address: http://www.affymax.com
CEO: Richard Brenner
No. of Employees: 304
Common Issue Type: CS
Business Description:Affymax, Inc., is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.1305 Unchanged 0.0 0.11 0.1308  0.13 0.13 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 4.9 37.5 0.00 -0.39 0.00 0.0 0.0 1.17 - 0.08
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.13$
PE Ratio - LTM0.0
Market Capitalisation4.9mil
Latest Shares Outstanding37.5mil
Earnings pS (EPS)-0.39$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float37.4mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue20.10%
Research & Devlopment (R&D) as % of Revenue8.70%
Gross Profit Margin100.0%
EBITDA Margin-1044.2%
Pre-Tax Profit Margin0.0%
Assets Turnover2.2%
Return on Assets (ROA)-23.0%
Return on Equity (ROE)-421.0%
Return on Capital Invested (ROCI)-166.4%
Current Ratio0.7
Leverage Ratio (Assets/Equity)
Interest Cover-9.6
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS-0.07$
Cash pS0.00$
Book-Value pS0.14$
Tangible Book-Value pS-0.04$
Cash Flow pS-0.22$
Free Cash Flow pS-0.22$
KEY FIGURES (LTM): Price info
Price/Book Ratio0.98
Price/Tangible Book Ratio0.00
Price/Cash Flow-0.6
Price/Free Cash Flow-0.6
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.230.86-84-7
4 Weeks0.130.130.130.230.86-18
13 Weeks0.130.13577810.081.17-18
26 Weeks577810.230.230.101.1730
52 Weeks0.080.080.090.230.0830
YTD0.080.08-0.230.08-1-84
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.080.080.160.160.320.780.78
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue459721311880831188083
Income459721345972138899598
Dividend88995983848193338481933
Capital Spending76594250NA76594250
R&D2832626NA2832626
Normalized Inc.8899598NA8899598
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-56-95-95
Earnings %-98-98-96
EPS %262727
EPS $-9666
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio7443000
Quick Ratio (Acid Test)1121000
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS-1428000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)101000
Debt Ratio8871000
Total Debt/Equity (Gearing Ratio)Sp
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities8871000
Interest Cover
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM39,745,564.00
Enterprise Value (EV)/EBITDA-0.00
Enterprise Value (EV)/Free Cash Flow-382.11
Dividend Yield561148
Price/Tangible Book Ratio - LTM1992
Price/Book Ratio - LTM304785
Price/Cash Flow Ratio0.7
Price/Free Cash Flow Ratio - LTM1992
Price/Sales Ratio-26.00
P/E Ratio (1 month ago) - LTM39745564
P/E Ratio (26 weeks ago) - LTM56126398
P/E Ratio (52 weeks ago) - LTM56126398
5-Y High P/E Ratio76805989
5-Y Low P/E Ratio73468399
5-Y Average P/E Ratio102990
Current P/E Ratio as % of 5-Y Average P/E102990
P/E as % of Industry Group229,860.0
P/E as % of Sector Segment229,860.0
Current 12 Month Normalized P/E Ratio - LTM108,007.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM0.7
Book Value pS - LTM304785
Capital Invested pS0.00
Cash pS - LTM76642
Cash Flow pS - LTM135.63
Free Cash Flow pS - LTM135.63
Earnings pS (EPS)-100
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin
Net Profit Margin - 5YEAR AVRG.2014-07-31
Equity Productivity0.00
Return on Equity (ROE)-1428000
Return on Equity (ROE) - 5YEAR AVRG.5061162
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-73
Assets Productivity101,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.5061162
Gross Profit Margin229860
Gross Profit Margin - 5YEAR AVRG.-73
EBITDA Margin - LTM139056
EBIT Margin - LTM229860
Pre-Tax Profit Margin
Pre-Tax Profit Margin - 5YEAR AVRG.37490095
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle8,871,923
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio8871000
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover101000
Revenue per $ Cash581000
Revenue per $ Plant581000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue-10000000
SG&A Expense as % of Revenue - 5YEAR AVRG.37490095
Research & Devlopment (R&D) as % of Revenue-10000000
R&D Expense as % of Revenue - 5YEAR AVRG.-10000000

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us usotc affy141219 06:44